Literature DB >> 1565831

[Infectious agents associated with exacerbations of chronic obstructive bronchopneumopathies and asthma attacks].

F Philit1, J Etienne, A Calvet, J F Mornex, V Trillet, M Aymard, J Brune, J F Cordier.   

Abstract

Infections of the respiratory airways are frequently responsible for exacerbations of chronic obstructive pulmonary disease (COPD) and attacks of asthma. However, the causal infectious agents in practice are rarely precisely identified. We have undertaken a prospective study with the aim of researching into the bacteria and viruses associated with these exacerbations. Forty-seven patients who were in hospital between 1987 and 1989 for attacks of asthma (13 episodes) or exacerbations of COPD (35 episodes) were included in this study. The microbiological analysis consisted of: 1) the bacteriology of expectorated material or the products aspirated by fibroscopy with direct examination, quantitative cytology and culture; 2) samples taken from the nasal airways to identify and isolate pneumotropic viruses and mycoplasma; 3) serial serology looking for antibodies against pneumotropic bacteria and viruses. One of more infectious agents were shown in 47% of the episode studies of which 57% were exacerbations of COPD and treated 23% attacks of asthma. In the cases COPD bacteria were identified in 13 cases including Haemophilus influenzae [3], Streptococcus pneumoniae [3], Pseudomonas aeruginosa [3]. Amongst the 14 viruses recovered, the influenza virus [8] and the respiratory syncytial virus (VRS) [4] predominated. In 14 cases of acute asthma only 4 infectious agents were shown; Mycoplasma pneumoniae, influenza A, VRS and parainfluenza virus. The influenza virus was the agent most frequently discovered (26%) during the course of exacerbation of COPD and of asthma.

Entities:  

Mesh:

Year:  1992        PMID: 1565831

Source DB:  PubMed          Journal:  Rev Mal Respir        ISSN: 0761-8425            Impact factor:   0.622


  7 in total

Review 1.  Oral corticosteroids for exacerbations of chronic obstructive pulmonary disease.

Authors:  J A Wedzicha
Journal:  Thorax       Date:  2000-08       Impact factor: 9.139

Review 2.  Influenza vaccines. A reappraisal of their use.

Authors:  A M Palache
Journal:  Drugs       Date:  1997-12       Impact factor: 9.546

Review 3.  Zanamivir: a review of clinical safety in individuals at high risk of developing influenza-related complications.

Authors:  S Gravenstein; S L Johnston; E Loeschel; A Webster
Journal:  Drug Saf       Date:  2001       Impact factor: 5.606

Review 4.  Challenge models to assess new therapies in chronic obstructive pulmonary disease.

Authors:  René van der Merwe; Nestor A Molfino
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2012-09-13

5.  No direct association between asthma and the microbiome based on currently available techniques.

Authors:  Josef Yayan
Journal:  Medicine (Baltimore)       Date:  2014-12       Impact factor: 1.889

6.  Importance of viral and bacterial infections in chronic obstructive pulmonary disease exacerbations.

Authors:  Gaston De Serres; Noël Lampron; Jacques La Forge; Isabelle Rouleau; Jean Bourbeau; Karl Weiss; Béatrice Barret; Guy Boivin
Journal:  J Clin Virol       Date:  2009-08-07       Impact factor: 3.168

Review 7.  Exacerbations: etiology and pathophysiologic mechanisms.

Authors:  Jadwiga A Wedzicha
Journal:  Chest       Date:  2002-05       Impact factor: 9.410

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.